Table 2 |
||||||
|
Significant KEGG identifiers detected based on the differentially expressed transcripts in cluster 2 for the acute phase response to E. coli infection* |
||||||
|
KEGG ID |
P value |
Odds Ratio |
Exp Count |
Count |
Size |
Term |
|
|
||||||
|
830 |
0.00011 |
19.46957 |
0.257269 |
4 |
24 |
Retinol metabolism |
|
71 |
0.002574 |
12.51056 |
0.278708 |
3 |
26 |
Fatty acid metabolism |
|
1100 |
0.016481 |
2.126324 |
6.817621 |
13 |
636 |
Metabolic pathways |
|
61 |
0.021326 |
93.55556 |
0.021439 |
1 |
2 |
Fatty acid biosynthesis |
|
980 |
0.029004 |
8.222903 |
0.267988 |
2 |
25 |
Metabolism of xenobiotics by cytochrome P450 |
|
561 |
0.031206 |
7.879108 |
0.278708 |
2 |
26 |
Glycerolipid metabolism |
|
982 |
0.035802 |
7.270856 |
0.300147 |
2 |
28 |
Drug metabolism - cytochrome P450 |
|
|
||||||
|
*A hypergeometric gene set enrichment test was performed based on cluster 2 of the contrast T24 vs. C24. Overrepresentation of gene sets defined by the KEGG database was tested using the Fisher's exact test. A gene set was considered significant if P < 0.05. |
||||||
|
Buitenhuis et al. BMC Genomics 2011 12:130 doi:10.1186/1471-2164-12-130 |
||||||